Link to full study:
Paper · Osteoarthritis Cartilage · 2006Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial.Conclusion: MSM (3g twice a day) improved symptoms of pain and physical function during the short intervention without major adverse events. The benefits and safety of MSM in managing OA and long-term use cannot be confirmed from this pilot trial, but its potential clinical application is examined. Underlying mechanisms of action and need for further investigation of MSM are discussed.pubmed.ncbi.nlm.nih.gov
GLP-1 drugs linked to lower risk of knee replacement in knee osteoarthritis
A shared Discover Magazine report says a records-based study found people with knee osteoarthritis taking GLP-1 receptor agonists had a significantly lower long-term risk of knee replacement, strongest with semaglutide and tirzepatide and with longer treatment. Louis added only hashtags; this is observational data.


